NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/07/2024
Back to search
Official data from USPTO
GCAD GLOBAL COUNCIL ON ALZHEIMER'S DISEASE COMMUNITY HOME CLINIC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000086688657Class
16, 35, 41, 42, 44
Filing
86688657
Registration
5536104
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
49
Latest update
12/07/2024
Trademark type
Combined
Nice classes
16, 35, 41, 42, 44
Filing date
07/09/2015
Registration date
08/07/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/07/2024
Last transaction
12/07/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/31/2016
First use in commerce
10/31/2016
Drawing code
3
Owner type
03
Owner location
Rockville, MD
Examiner
MUNN LEWIS, LAKEISHA S
Current location
Historical data usage
Mark description
The mark consists of a blue globe with black outlining and a design of a small city skyline. The small city buildings are depicted in blue, grey, brown, orange and white and the buildings are outlined in black, and there is a green section depicting grass. A stylized black caduceus symbol appears on one of the buildings. The stylized words "COMMUNITY", "HOME", and "CLINIC" appear above the globe in black on a yellow background; the stylized letters "GCAD" appear in black on a purple banner across the globe with the banner featuring black and white highlighting. They stylized wording "GLOBAL COUNCIL ON ALZHEIMER'S DISEASE" appears below in black.
Holders and representatives
Holders
Otsuka America Pharmaceutical, Inc.
Representatives
B. Brett Heavner Finnegan Henderson Farabow Garrett & Dunner Ll
Technical classification
Nice Classes
Class 16Class 35Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 16
Printed materialsposters in the field of Alzheimer's disease care and treatment
Class 35
Promoting awareness of Alzheimer's disease care and treatment
Class 41
on-line publishing of electronic publications
Class 42
Research and development in the field of Alzheimer's disease care and treatment
Class 44
Providing a website featuring information in the field of Alzheimer's disease care and treatment
Publications
History of USPTO decisions and trademark events.
49 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/07/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/07/2024
E815
TEAS SECTION 8 & 15 RECEIVED
06/28/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/07/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
08/07/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/03/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/02/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/18/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/18/2018
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/15/2018
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/21/2018
GNFR
FINAL REFUSAL E-MAILED
03/21/2018
CNFR
SU - FINAL REFUSAL - WRITTEN
03/21/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/16/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/16/2018
ALIE
ASSIGNED TO LIE
02/15/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/09/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/18/2017
GNRT
NON-FINAL ACTION E-MAILED
08/18/2017
CNRT
SU - NON-FINAL ACTION - WRITTEN
08/18/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/14/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/13/2017
EX2G
SOU EXTENSION 2 GRANTED
07/13/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/10/2017
IUAF
USE AMENDMENT FILED
06/27/2017
EXT2
SOU EXTENSION 2 FILED
06/27/2017
EEXT
SOU TEAS EXTENSION RECEIVED
06/27/2017
EISU
TEAS STATEMENT OF USE RECEIVED
06/27/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/27/2016
EX1G
SOU EXTENSION 1 GRANTED
12/23/2016
EXT1
SOU EXTENSION 1 FILED
12/23/2016
EEXT
SOU TEAS EXTENSION RECEIVED
12/23/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/28/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/03/2016
PUBO
PUBLISHED FOR OPPOSITION
05/03/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/13/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/29/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/02/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/02/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/02/2016
DOCK
ASSIGNED TO EXAMINER
10/19/2015
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
09/08/2015
GPRA
PRIORITY ACTION E-MAILED
09/08/2015
CPRA
PRIORITY ACTION WRITTEN
09/08/2015
DOCK
ASSIGNED TO EXAMINER
08/30/2015
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/15/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/14/2015
NWAP
NEW APPLICATION ENTERED
07/13/2015
Continuous trademark protection
Get notified about every new filing that threatens GCAD GLOBAL COUNCIL ON ALZHEIMER'S DISEASE COMMUNITY HOME CLINIC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.